首页> 外国专利> TREATMENT AND PREVENTION OF BENIGN NEVUS PIGMENTOSIS (NEVUSES) BY MEANS OF ARTEMISININ AND ITS DERIVATIVES

TREATMENT AND PREVENTION OF BENIGN NEVUS PIGMENTOSIS (NEVUSES) BY MEANS OF ARTEMISININ AND ITS DERIVATIVES

机译:青蒿素及其衍生物的治疗和预防良性痣(痣)。

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention relates to medicine. Benign nevus pigmentosis of skin can be treated by local application, in particular, external application, of composition of active ingredients of formula (I), where in formula (I) X is CO, CHOZ or CHNRZ, where Z is selected from hydrogen; unbranched or branched (C1-C6) alkyl; unbranched or branched (C2-C6) alkenyl; unbranched or branched (C2-C6) alkinyl, (C3-C8) cycloalkyl; (C6-C24) aryl; (C7-C24) aralkyl; m- and n-CH2(C6H4)COOM; COR3; CSR3; C(NR6)R3; SOR4; SO2OM; SO2NR7R8; SO2O-artemisinyl; SO2NH- artemisinyl; POR4R5 and PSR4R5; where R3 is unbranched or branched (C1-C6) alkyl; unbranched or branched (C2-C6) alkoxy; unbranched or branched (C2-C6) alkenyl; unbranched or branched (C2-C6) alkinyl; (C3-C8) cycloalkyl; (C6-C24) aryl; (C6-C10) aryloxy; (C7-C24) aralkyl; -(CH2)n-COOM, where n it is integer from 1 to 6; or 10α-di-hydro artemisinyl; R4 and R5 are selected independently on each other from unbranched or branched (C1-C6) alkyl; unbranched or branched (C2-C6) alkenyl; unbranched or branched (C2-C6) alkinyl; (C3-C8) cycloalkyl; (C6-C24) aryl; (C7-C24) aralkyl; OM; unbranched or branched (C1-C6) alkoxy; (C6-C10) aryloxy and NR7 R8; R6 are selected from unbranched or branched (C1-C6) alkyl; unbranched or branched (C2-C6) alkenyl; unbranched or branched (C2-C6) alkinyl; (C3-C8) cycloalkyl; (C6-C24) aryl and (C7-C24) aralkyl; M is hydrogen or pharmaceutically acceptable cation; and R7 and R8 are independently on each other hydrogen or unbranched or branched (C1-C6) alkyl, or R7 and R8 together form (C4-C6) alkylene bridge; and R is selected from hydrogen and groups, listed for R6 . These compounds are also effective in prevention of acquired nevuses from nevoid cells.;EFFECT: during treatment with formula (1) compounds healthy tissue is not damaged, and treatment is painless and simple.;26 cl, 1 tbl, 10 ex
机译:技术领域:药物涉及发明。皮肤的良性痣色素沉着可以通过局部施用,特别是外部施用式(I)活性成分的组合物来治疗,其中式(I)中X为CO,CHOZ或CHNRZ,其中Z选自氢;非支链或支链(C 1 -C 6 )烷基;非支链或支链(C 2 -C 6 )烯基;非支链或支链(C 2 -C 6 )炔基,(C 3 -C 8 )环烷基; (C 6 -C 24 )芳基; (C 7 -C 24 )芳烷基; m-和n-CH 2 (C 6 H 4 )COOM; COR 3 ; CSR 3 ; C(NR 6 )R 3 ; SOR 4 ; SO 2 OM; SO 2 NR 7 R 8 ; SO 2 O-青蒿素; SO 2 NH-青蒿素; POR 4 R 5 和PSR 4 R 5 ;其中R 3 是直链或支链的(C 1 -C 6 )烷基;非支链或支链(C 2 -C 6 )烷氧基;非支链或支链(C 2 -C 6 )烯基;非支链或支链(C 2 -C 6 )炔基; (C 3 -C 8 )环烷基; (C 6 -C 24 )芳基; (C 6 -C 10 )芳氧基; (C 7 -C 24 )芳烷基; -(CH 2 n -COOM,其中n是1到6的整数;或10α-二氢青蒿素; R 4 和R 5 从直链或支链(C 1 -C 6 )彼此独立选择烷基;非支链或支链(C 2 -C 6 )烯基;非支链或支链(C 2 -C 6 )炔基; (C 3 -C 8 )环烷基; (C 6 -C 24 )芳基; (C 7 -C 24 )芳烷基; OM;非支链或支链(C 1 -C 6 )烷氧基; (C 6 -C 10 )芳氧基和NR 7 R 8 ; R 6 选自直链或支链(C 1 -C 6 )烷基;非支链或支链(C 2 -C 6 )烯基;非支链或支链(C 2 -C 6 )炔基; (C 3 -C 8 )环烷基; (C 6 -C 24 )芳基和(C 7 -C 24 )芳烷基; M是氢或药学上可接受的阳离子;和R 7 和R 8 彼此独立地为氢原子或未分支或支链的(C 1 -C 6 ),或R 7 和R 8 一起形成(C 4 -C 6 )亚烷基桥; R选自氢和R 6 列出的基团。这些化合物也可有效预防从空细胞获得的痣。效果:在用式(1)化合物治疗期间,健康组织没有受到损害,并且治疗无痛且简单。; 26 cl,1 tbl,10 ex

著录项

  • 公开/公告号RU2423974C2

    专利类型

  • 公开/公告日2011-07-20

    原文格式PDF

  • 申请/专利权人 EHPIFARM GMBKH;

    申请/专利号RU20080119463

  • 发明设计人 ZIFT KARTER ROZMARI (CH);

    申请日2006-10-19

  • 分类号A61K31/335;A61K9/70;A61P17;

  • 国家 RU

  • 入库时间 2022-08-21 17:48:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号